Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning | Zendy

Patrick Gould | Zendy; Babette S. Zemel | Zendy; Elena Taratuta | Zendy; Joshua F. Baker | Zendy

Open Access

Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning

Author(s) -

Patrick Gould,

Babette S. Zemel,

Elena Taratuta,

Joshua F. Baker

Publication year - 2020

Publication title -

the journal of rheumatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.577

H-Index - 178

eISSN - 1499-2752

pISSN - 0315-162X

DOI - 10.3899/jrheum.200673

Subject(s) - medicine , rheumatoid arthritis , resistin , lean body mass , fibroblast growth factor 23 , risk factor , adipokine , endocrinology , gastroenterology , obesity , insulin resistance , body weight , parathyroid hormone , calcium

This study evaluated associations between fibroblast growth factor (FGF)-21, an adipokine associated with metabolic stress, and adverse longitudinal changes in body composition and physical functioning in patients with rheumatoid arthritis (RA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research